IDiyas

For the Inventor, By the Inventor

Foster City, CA, United States of America

Li Tang

USPTO Granted Patents = 15


Average Co-Inventor Count = 4.6

ph-index = 5

Forward Citations = 117(Granted Patents)


Company Filing History:

goldMedal13 out of 110 
 
Kosan Biosciences Incorporated
 patents
silverMedal1 out of 1 
 
Kason Biosciences, Inc.
 patent
bronzeMedal1 out of 1 
 
Kosam Biosciences, Inc.
 patent

Years Active: 2000-2010

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 7732186 - Recombinant methods and materials for producing epothilone and epothilone derivatives (2010-06-08),
2. 7402421 - Recombinant methods and materials for producing epothilone and epothilone derivatives (2008-07-22),
3. 7129071 - Recombinant methods and materials for producing epothilone and epothilone derivatives (2006-10-31),
4. 7070964 - Epothilone compounds and methods for making the same (2006-07-04),
5. 6921650 - Recombinant methods and materials for producing epothilone and epothilone derivatives (2005-07-26),
6. 6902913 - Recombinant narbonolide polyketide synthase (2005-06-07),
7. 6893859 - Epothilone derivatives and methods for making and using the same (2005-05-17),
8. 6858411 - Recombinant methods and materials for producing epothilone and epothilone derivatives (2005-02-22),
9. 6838265 - Overproduction hosts for biosynthesis of polyketides (2005-01-04),
10. 6583290 - 14-methyl epothilone derivatives (2003-06-24),
11. 6509455 - Recombinant narbonolide polyketide synthase (2003-01-21),
12. 6503741 - Polyketide synthase genes from Streptomyces venezuelae (2003-01-07),
13. 6303342 - Recombinant methods and materials for producing epothilones C and D (2001-10-16),
14. 6251636 - Recombinant oleandolide polyketide synthase (2001-06-26),
15. 6117659 - Recombinant narbonolide polyketide synthase (2000-09-12),

Title: The Innovative Contributions of Inventor Li Tang

Introduction

Li Tang, an accomplished inventor based in Foster City, CA, has made significant strides in the field of biotechnology, holding a remarkable 15 patents. Her groundbreaking work primarily focuses on recombinant methods and materials for producing epothilones and their derivatives, compounds that are crucial in the fight against cancer and other diseases.

Latest Patents

Li Tang's latest patents delve into recombinant nucleic acids that encode portions of the epothilone polyketide synthase (PKS). These innovative methods enable the expression of PKS genes in host cells, facilitating the production of epothilones, epothilone derivatives, and polyketides that serve as potent cancer chemotherapeutics, fungicides, and immunosuppressants. The technology behind her patents represents a significant advancement in the biosynthesis of valuable therapeutic agents.

Career Highlights

Throughout her career, Li Tang has contributed significantly to the biopharmaceutical sector, having worked at notable companies including Kosan Biosciences Incorporated and Kason Biosciences, Inc. Her expertise and innovative approaches have yielded numerous patents, reinforcing her position as a leader in the field of biotechnology.

Collaborations

Li has collaborated with esteemed professionals in her field, including Leonard Katz and Chaitan Khosla. These partnerships have fostered an environment of innovation and creativity, driving forward the development of new therapeutic technologies.

Conclusion

Inventor Li Tang's contributions to the field of biotechnology, particularly in the production of epothilones and related compounds, underscore her commitment to advancing medical science. With her extensive patent portfolio and collaborative spirit, she continues to be a significant figure in the landscape of innovative biopharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…